Changing microbiological profile and antimicrobial susceptibility of the isolates obtained from patients with infective endocarditis – The time to relook into the therapeutic guidelines
The microbiological profile, associated risk factors and demographic characteristics of patients with IE has changed in the recent times. In the present study, the antibiotic susceptibility profile of 66 isolates (40 from IDU and 26 from non IDU) recovered over a period of three years from the patie...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9707ec391e99437ea8e9ba9ef0d73683 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:9707ec391e99437ea8e9ba9ef0d73683 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:9707ec391e99437ea8e9ba9ef0d736832021-12-02T04:58:04ZChanging microbiological profile and antimicrobial susceptibility of the isolates obtained from patients with infective endocarditis – The time to relook into the therapeutic guidelines0019-483210.1016/j.ihj.2021.10.013https://doaj.org/article/9707ec391e99437ea8e9ba9ef0d736832021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S0019483221002327https://doaj.org/toc/0019-4832The microbiological profile, associated risk factors and demographic characteristics of patients with IE has changed in the recent times. In the present study, the antibiotic susceptibility profile of 66 isolates (40 from IDU and 26 from non IDU) recovered over a period of three years from the patients with definitive diagnosis of IE along with their absolute minimum inhibitory concentrations (MIC-μg/ml) was determined as per CLSI, 2017 guidelines. Staphylococcus aureus was found to be the predominant pathogen associated with IE out of which 90.2% isolates were MRSA, although none of the isolates were found resistant to vancomycin, teicoplanin, daptomycin and linezolid. Pseudomonas aeruginosa isolates were 100% susceptible to carbapenams, however variable resistance was observed against other antimicrobials. All Enterococci were found to be 100% susceptible to linezolid and daptomycin, whereas vancomycin resistant enterococci phenotype was observed in 25% of the Enterococcal isolates. A noticeable difference in the antimicrobial susceptibility profile and their MICs were observed in the present study, as compared to published literature across the globe and within the country. However, no statistically significant difference (λ 2 test, p > 0.01)in the AST pattern of isolates from IDU vs. Non IDU was observed. After reviewing the local antibiogram it seems that we need to have our own regional guidelines, which may partially replace the currently prevailing AHA/ESC guidelines.Rama GuptaVandana KaushalAbhishek GoyalPawan KumarDinesh GuptaRohit TandonAashita MahajanSonaal SinglaGurbhej SinghBhupinder SinghShibba Takkar ChhabraNaved AslamGurpreet S. WanderVeenu GuptaBishav MohanElsevierarticleInfective endocarditisMicrobiological profileMinimum inhibitory concentrationsGuidelinesIntravenous drug usersSurgeryRD1-811Diseases of the circulatory (Cardiovascular) systemRC666-701ENIndian Heart Journal, Vol 73, Iss 6, Pp 704-710 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Infective endocarditis Microbiological profile Minimum inhibitory concentrations Guidelines Intravenous drug users Surgery RD1-811 Diseases of the circulatory (Cardiovascular) system RC666-701 |
spellingShingle |
Infective endocarditis Microbiological profile Minimum inhibitory concentrations Guidelines Intravenous drug users Surgery RD1-811 Diseases of the circulatory (Cardiovascular) system RC666-701 Rama Gupta Vandana Kaushal Abhishek Goyal Pawan Kumar Dinesh Gupta Rohit Tandon Aashita Mahajan Sonaal Singla Gurbhej Singh Bhupinder Singh Shibba Takkar Chhabra Naved Aslam Gurpreet S. Wander Veenu Gupta Bishav Mohan Changing microbiological profile and antimicrobial susceptibility of the isolates obtained from patients with infective endocarditis – The time to relook into the therapeutic guidelines |
description |
The microbiological profile, associated risk factors and demographic characteristics of patients with IE has changed in the recent times. In the present study, the antibiotic susceptibility profile of 66 isolates (40 from IDU and 26 from non IDU) recovered over a period of three years from the patients with definitive diagnosis of IE along with their absolute minimum inhibitory concentrations (MIC-μg/ml) was determined as per CLSI, 2017 guidelines. Staphylococcus aureus was found to be the predominant pathogen associated with IE out of which 90.2% isolates were MRSA, although none of the isolates were found resistant to vancomycin, teicoplanin, daptomycin and linezolid. Pseudomonas aeruginosa isolates were 100% susceptible to carbapenams, however variable resistance was observed against other antimicrobials. All Enterococci were found to be 100% susceptible to linezolid and daptomycin, whereas vancomycin resistant enterococci phenotype was observed in 25% of the Enterococcal isolates. A noticeable difference in the antimicrobial susceptibility profile and their MICs were observed in the present study, as compared to published literature across the globe and within the country. However, no statistically significant difference (λ 2 test, p > 0.01)in the AST pattern of isolates from IDU vs. Non IDU was observed. After reviewing the local antibiogram it seems that we need to have our own regional guidelines, which may partially replace the currently prevailing AHA/ESC guidelines. |
format |
article |
author |
Rama Gupta Vandana Kaushal Abhishek Goyal Pawan Kumar Dinesh Gupta Rohit Tandon Aashita Mahajan Sonaal Singla Gurbhej Singh Bhupinder Singh Shibba Takkar Chhabra Naved Aslam Gurpreet S. Wander Veenu Gupta Bishav Mohan |
author_facet |
Rama Gupta Vandana Kaushal Abhishek Goyal Pawan Kumar Dinesh Gupta Rohit Tandon Aashita Mahajan Sonaal Singla Gurbhej Singh Bhupinder Singh Shibba Takkar Chhabra Naved Aslam Gurpreet S. Wander Veenu Gupta Bishav Mohan |
author_sort |
Rama Gupta |
title |
Changing microbiological profile and antimicrobial susceptibility of the isolates obtained from patients with infective endocarditis – The time to relook into the therapeutic guidelines |
title_short |
Changing microbiological profile and antimicrobial susceptibility of the isolates obtained from patients with infective endocarditis – The time to relook into the therapeutic guidelines |
title_full |
Changing microbiological profile and antimicrobial susceptibility of the isolates obtained from patients with infective endocarditis – The time to relook into the therapeutic guidelines |
title_fullStr |
Changing microbiological profile and antimicrobial susceptibility of the isolates obtained from patients with infective endocarditis – The time to relook into the therapeutic guidelines |
title_full_unstemmed |
Changing microbiological profile and antimicrobial susceptibility of the isolates obtained from patients with infective endocarditis – The time to relook into the therapeutic guidelines |
title_sort |
changing microbiological profile and antimicrobial susceptibility of the isolates obtained from patients with infective endocarditis – the time to relook into the therapeutic guidelines |
publisher |
Elsevier |
publishDate |
2021 |
url |
https://doaj.org/article/9707ec391e99437ea8e9ba9ef0d73683 |
work_keys_str_mv |
AT ramagupta changingmicrobiologicalprofileandantimicrobialsusceptibilityoftheisolatesobtainedfrompatientswithinfectiveendocarditisthetimetorelookintothetherapeuticguidelines AT vandanakaushal changingmicrobiologicalprofileandantimicrobialsusceptibilityoftheisolatesobtainedfrompatientswithinfectiveendocarditisthetimetorelookintothetherapeuticguidelines AT abhishekgoyal changingmicrobiologicalprofileandantimicrobialsusceptibilityoftheisolatesobtainedfrompatientswithinfectiveendocarditisthetimetorelookintothetherapeuticguidelines AT pawankumar changingmicrobiologicalprofileandantimicrobialsusceptibilityoftheisolatesobtainedfrompatientswithinfectiveendocarditisthetimetorelookintothetherapeuticguidelines AT dineshgupta changingmicrobiologicalprofileandantimicrobialsusceptibilityoftheisolatesobtainedfrompatientswithinfectiveendocarditisthetimetorelookintothetherapeuticguidelines AT rohittandon changingmicrobiologicalprofileandantimicrobialsusceptibilityoftheisolatesobtainedfrompatientswithinfectiveendocarditisthetimetorelookintothetherapeuticguidelines AT aashitamahajan changingmicrobiologicalprofileandantimicrobialsusceptibilityoftheisolatesobtainedfrompatientswithinfectiveendocarditisthetimetorelookintothetherapeuticguidelines AT sonaalsingla changingmicrobiologicalprofileandantimicrobialsusceptibilityoftheisolatesobtainedfrompatientswithinfectiveendocarditisthetimetorelookintothetherapeuticguidelines AT gurbhejsingh changingmicrobiologicalprofileandantimicrobialsusceptibilityoftheisolatesobtainedfrompatientswithinfectiveendocarditisthetimetorelookintothetherapeuticguidelines AT bhupindersingh changingmicrobiologicalprofileandantimicrobialsusceptibilityoftheisolatesobtainedfrompatientswithinfectiveendocarditisthetimetorelookintothetherapeuticguidelines AT shibbatakkarchhabra changingmicrobiologicalprofileandantimicrobialsusceptibilityoftheisolatesobtainedfrompatientswithinfectiveendocarditisthetimetorelookintothetherapeuticguidelines AT navedaslam changingmicrobiologicalprofileandantimicrobialsusceptibilityoftheisolatesobtainedfrompatientswithinfectiveendocarditisthetimetorelookintothetherapeuticguidelines AT gurpreetswander changingmicrobiologicalprofileandantimicrobialsusceptibilityoftheisolatesobtainedfrompatientswithinfectiveendocarditisthetimetorelookintothetherapeuticguidelines AT veenugupta changingmicrobiologicalprofileandantimicrobialsusceptibilityoftheisolatesobtainedfrompatientswithinfectiveendocarditisthetimetorelookintothetherapeuticguidelines AT bishavmohan changingmicrobiologicalprofileandantimicrobialsusceptibilityoftheisolatesobtainedfrompatientswithinfectiveendocarditisthetimetorelookintothetherapeuticguidelines |
_version_ |
1718400966122799104 |